Status:
COMPLETED
GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region
Lead Sponsor:
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
Collaborating Sponsors:
Agence Regionale de Sante d'Ile de France
National Agency of Public Health
Conditions:
Pertussis Vaccine
Healthcare Worker Patient Transmission
Eligibility:
All Genders
19+ years
Brief Summary
Implementation of organizational adjustments can enhance involvement of healthcare teams in carrying out flu and pertussis vaccinations, and optimizing access to vaccines for women and their families....
Detailed Description
Multicentre, descriptive study conducted in a declarative manner and supplemented by direct observation by an investigator. Main objectives: * Assess existing practices of the various actors involve...
Eligibility Criteria
Inclusion
- Pregnant and postpartum women over 18 medically followed in maternity wards included. Femmes enceintes ou en post-partum :
- Health professionals over 18 working in maternity wards included.
Exclusion
- Women under the protection of a conservator Temporary Health staff
Key Trial Info
Start Date :
May 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT04494581
Start Date
May 3 2019
End Date
March 30 2020
Last Update
July 31 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternité Hôpital privé
Antony, France, 92160
2
Maternité Hôpital Jean Verdier
Bondy, France, 93143
3
Maternité Notre Dame de Bon Secours - GH Paris St Joseph
Paris, France, 75014
4
Maternité Port Royal
Paris, France, 75014